Board of Directors
The board of directors is comprised of:
-
David Baltimore, Ph.D.,
Professor of Biology at California Institute of Technology and the recipient of the 1975 Nobel Prize in Physiology or Medicine -
Stanley Crooke, M.D., Ph.D.,
Chairman and Chief Executive Officer, Isis Pharmaceuticals -
Barry Greene,
President and Chief Operating Officer, Alnylam Pharmaceuticals -
John Maraganore, Ph.D.,
(Chairman) Chief Executive Officer, Alnylam Pharmaceuticals and Chairman of the Board of Directors for Regulus Therapeutics -
B. Lynne Parshall, Esq.,
Director, Chief Operating Officer, Chief Financial Officer & Secretary, Isis Pharmaceuticals -
Stelios Papadopoulos, Ph.D.,
Co-founder of several biotechnology companies and former vice chairman of Cowen & Company -
Kleanthis G. Xanthopoulos, Ph.D.,
President and Chief Executive Officer, Regulus Therapeutics
